Mc Carthy Asset Management, Inc. Gilead Sciences, Inc. Transaction History

Mc Carthy Asset Management, Inc.

$151 Million
Q2 2024

A detailed history of Mc Carthy Asset Management, Inc. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Mc Carthy Asset Management, Inc. holds 130,363 shares of GILD stock, worth $10.9 Million. This represents 5.91% of its overall portfolio holdings.

Number of Shares

130,363

Previous 130,321 0.03%

Holding current value

$10.9 Million

Previous $9.55 Million 6.31%

% of portfolio

5.91%

Previous 6.56%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$63.15 - $72.88 $2,652 - $3,060	42 Added 0.03%	130,363 $8.94 Million
Q1 2024 May 08, 2024	SELL	$71.58 - $87.29 $89,618 - $109,287	-1,252 Reduced 0.95%	130,321 $9.55 Million
Q4 2023 Feb 02, 2024	BUY	$73.27 - $83.09 $146 - $166	2 Added 0.0%	131,573 $10.7 Million
Q3 2023 Nov 15, 2023	SELL	$73.94 - $80.67 $71,352 - $77,846	-965 Reduced 0.73%	131,571 $9.86 Million
Q2 2023 Aug 04, 2023	SELL	$76.01 - $86.7 $19,154 - $21,848	-252 Reduced 0.19%	132,536 $10.2 Million
Q1 2023 May 08, 2023	SELL	$77.31 - $88.08 $17,703 - $20,170	-229 Reduced 0.17%	132,788 $11 Million
Q4 2022 Jan 20, 2023	SELL	$62.32 - $89.47 $1.06 Million - $1.52 Million	-16,967 Reduced 11.31%	133,017 $0
Q3 2022 Oct 28, 2022	SELL	$59.54 - $68.01 $27,805 - $31,760	-467 Reduced 0.31%	149,984 $9.25 Million
Q2 2022 Jul 20, 2022	BUY	$57.72 - $65.01 $115 - $130	2 Added 0.0%	150,451 $9.3 Million
Q1 2022 May 11, 2022	BUY	$57.92 - $72.58 $115 - $145	2 Added 0.0%	150,449 $8.94 Million
Q4 2021 Feb 07, 2022	SELL	$64.88 - $73.64 $91,805 - $104,200	-1,415 Reduced 0.93%	150,447 $10.9 Million
Q3 2021 Nov 12, 2021	SELL	$67.69 - $73.03 $165,163 - $178,193	-2,440 Reduced 1.58%	151,862 $10.6 Million
Q2 2021 Aug 05, 2021	SELL	$63.47 - $69.35 $604,996 - $661,044	-9,532 Reduced 5.82%	154,302 $10.6 Million
Q1 2021 May 13, 2021	SELL	$60.0 - $68.46 $516,180 - $588,961	-8,603 Reduced 4.99%	163,834 $10.6 Million
Q4 2020 Feb 01, 2021	BUY	$56.65 - $64.55 $9.77 Million - $11.1 Million	172,437 New	172,437 $10 Million

Others Institutions Holding GILD

# of Institutions

1,879

Shares Held

1.02B

Call Options Held

12M

Put Options Held

8.96M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $105B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mc Carthy Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Mc Carthy Asset Management, Inc. with notifications on news.

Account

Mc Carthy Asset Management, Inc. Gilead Sciences, Inc. Transaction History